{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:18:55Z","timestamp":1790684335380,"version":"4.1.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2002,7,1]],"date-time":"2002-07-01T00:00:00Z","timestamp":1025481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Advances in Renal Replacement Therapy"],"published-print":{"date-parts":[[2002,7]]},"DOI":"10.1053\/jarr.2002.34843","type":"journal-article","created":{"date-parts":[[2002,8,29]],"date-time":"2002-08-29T19:51:36Z","timestamp":1030650696000},"page":"184-192","source":"Crossref","is-referenced-by-count":19,"title":["Hyperphosphatemia in end-stage renal disease"],"prefix":"10.1053","volume":"9","author":[{"given":"Olafur S.","family":"Indridason","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.Darryl","family":"Quarles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/jarr.2002.34843_NEWBIB1","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and calcium \u00d7 phosphate product with mortality risk in chronic hemodialysis patients: a national study","volume":"31","author":"Block","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/jarr.2002.34843_NEWBIB2","first-page":"445","article-title":"Prevention and management of renal osteodystrophy in dialysis patients","author":"Indridason","year":"1998"},{"key":"10.1053\/jarr.2002.34843_NEWBIB3","first-page":"3860","article-title":"Predictors of short-term changes in serum intact parathyroid hormone levels in hemodialysis patients: role of phosphorus, calcium, and gender","volume":"83","author":"Indridason","year":"1998","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1053\/jarr.2002.34843_NEWBIB4","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1681\/ASN.V12102131","article-title":"Association of elevated serum PO(4), Ca \u00d7 PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients","volume":"12","author":"Ganesh","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/jarr.2002.34843_NEWBIB5","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0002-9343(88)80237-7","article-title":"Myocardial calcification and cardiac dysfunction in chronic renal failure","volume":"85","author":"Rostand","year":"1988","journal-title":"Am J Med"},{"key":"10.1053\/jarr.2002.34843_NEWBIB6","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2214\/ajr.149.5.881","article-title":"Metastatic calcification of the heart and lungs in end-stage renal disease: detection and quantification by dual-energy digital chest radiography","volume":"149","author":"Sanders","year":"1987","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/jarr.2002.34843_NEWBIB7","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1093\/ndt\/13.8.2037","article-title":"Cardiac valve calcification in haemodialysis patients: role of calcium-phosphate metabolism","volume":"13","author":"Ribeiro","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/jarr.2002.34843_NEWBIB8","doi-asserted-by":"crossref","first-page":"S238","DOI":"10.1046\/j.1523-1755.1999.07163.x","article-title":"Factors associated with calcification of the abdominal aorta in hemodialysis patients","volume":"71","author":"Kimura","year":"1999","journal-title":"Kidney Int Suppl"},{"key":"10.1053\/jarr.2002.34843_NEWBIB9","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0272-6386(00)70064-3","article-title":"Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management","volume":"35","author":"Block","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/jarr.2002.34843_NEWBIB10","first-page":"520","article-title":"Renal tranport of calcium, magnesium, and phosphate","author":"Suki","year":"2000"},{"key":"10.1053\/jarr.2002.34843_NEWBIB11","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1210\/jcem-67-5-876","article-title":"Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and several renal failure","volume":"67","author":"Pitts","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/jarr.2002.34843_NEWBIB12","doi-asserted-by":"crossref","first-page":"347","DOI":"10.5694\/j.1326-5377.1994.tb138236.x","article-title":"Phosphate enema poisoning in children","volume":"160","author":"Craig","year":"1994","journal-title":"Med J Austral"},{"key":"10.1053\/jarr.2002.34843_NEWBIB13","first-page":"G389","article-title":"Vitamin D increases tight-junction conductance and paracellular Ca2+ transport in Caco-2 cell cultures","volume":"274","author":"Chirayath","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1053\/jarr.2002.34843_NEWBIB14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1126\/science.285.5424.103","article-title":"Paracellin-1, a renal tight junction protein required for paracellular Mg2+ resorption","volume":"285","author":"Simon","year":"1999","journal-title":"Science"},{"key":"10.1053\/jarr.2002.34843_NEWBIB15","first-page":"115","article-title":"Mechanism and regulation of intestinal phosphate absorption","volume":"16","author":"Cross","year":"1990","journal-title":"Miner Electrol Metabol"},{"key":"10.1053\/jarr.2002.34843_NEWBIB16","first-page":"F1017","article-title":"Coordinate regulation of rat renal parathyroid hormone receptor mRNA and Na-Pi cotransporter mRNA and protein","volume":"268","author":"Kilav","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1053\/jarr.2002.34843_NEWBIB17","first-page":"G96","article-title":"Stanniocalcin: a novel protein regulating calcium and phosphate transport across mammalian intestine","volume":"274","author":"Madsen","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1053\/jarr.2002.34843_NEWBIB18","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/ki.1989.247","article-title":"Calcium acetate, an effective phosphorus binder in patients with renal failure","volume":"36","author":"Mai","year":"1989","journal-title":"Kidney Int"},{"key":"10.1053\/jarr.2002.34843_NEWBIB19","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/ki.1986.252","article-title":"The absorption of dietary phosphorus and calcium in hemodialysis patients","volume":"30","author":"Ramirez","year":"1986","journal-title":"Kidney Int"},{"key":"10.1053\/jarr.2002.34843_NEWBIB20","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/ki.1997.39","article-title":"Effective suppression of parathyroid hormone by 1 alpha-hydroxy-vitamin D2 in hemodialysis patients with moderate to severe secondary hyperparathyroidism","volume":"51","author":"Tan","year":"1997","journal-title":"Kidney Int"},{"key":"10.1053\/jarr.2002.34843_NEWBIB21","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1681\/ASN.V981427","article-title":"19-nor-1-alpha-25-dihydroxyvitamin D-2 (paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis","volume":"9","author":"Martin","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/jarr.2002.34843_NEWBIB22","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1177\/039139888701000308","article-title":"Inorganic phosphate removal during different dialytic procedures","volume":"10","author":"Zucchelli","year":"1987","journal-title":"Int J Artif Org"},{"key":"10.1053\/jarr.2002.34843_NEWBIB23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0272-6386(12)80882-1","article-title":"Calcium and phosphorus fluxes during hemodialysis with low calcium dialysate","volume":"18","author":"Hou","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/jarr.2002.34843_NEWBIB24","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1046\/j.1523-1755.1998.00875.x","article-title":"Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis","volume":"53","author":"Mucsi","year":"1998","journal-title":"Kidney Int"},{"issue":"suppl","key":"10.1053\/jarr.2002.34843_NEWBIB25","first-page":"114","article-title":"Phosphate removal rate: a comparative study of five high-flux dialysers","volume":"2","author":"Chauveau","year":"1991","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/jarr.2002.34843_NEWBIB26","first-page":"152","article-title":"Hemodiafiltration\u2014a new treatment option for hyperphosphatemia in hemodialysis patients","volume":"52","author":"Zehnder","year":"1999","journal-title":"Clin Nephrol"},{"key":"10.1053\/jarr.2002.34843_NEWBIB27","first-page":"M463","article-title":"Phosphate removal during hemodialysis, hemodiafiltration, and hemofiltration. A reappraisal","volume":"37","author":"Man","year":"1991","journal-title":"ASAIO Transact"},{"key":"10.1053\/jarr.2002.34843_NEWBIB28","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/ki.1982.110","article-title":"Minerals, vitamin D, and parathyroid hormone in continuous ambulatory peritoneal dialysis","volume":"21","author":"Delmez","year":"1982","journal-title":"Kidney Int"},{"key":"10.1053\/jarr.2002.34843_NEWBIB29","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/ki.1982.109","article-title":"Metabolic balance studies and dietary protein requirements in patients undergoing continuous ambulatory peritoneal dialysis","volume":"21","author":"Blumenkrantz","year":"1982","journal-title":"Kidney Int"},{"key":"10.1053\/jarr.2002.34843_NEWBIB30","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1093\/ndt\/13.11.2853","article-title":"Daily home haemodialysis in The Netherlands: effects on metabolic control, haemodynamics, and quality of life","volume":"13","author":"Kooistra","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/jarr.2002.34843_NEWBIB31","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1046\/j.1525-1594.1998.06213.x","article-title":"Daily versus standard hemodialysis: one year experience","volume":"22","author":"Traeger","year":"1998","journal-title":"Artif Org"},{"key":"10.1053\/jarr.2002.34843_NEWBIB32","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000188606","article-title":"Long-term control of hyperparathyroidism in advanced renal failure by low-phosphorus low-protein diet supplemented with calcium (without changes in plasma calcitriol)","volume":"70","author":"Combe","year":"1995","journal-title":"Nephron"},{"issue":"suppl","key":"10.1053\/jarr.2002.34843_NEWBIB33","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/ndt\/13.suppl_3.65","article-title":"Is it possible to control hyperphosphataemia with diet, without inducing protein malnutrition?","volume":"3","author":"Rufino","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/jarr.2002.34843_NEWBIB34","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1172\/JCI113886","article-title":"Reduction of dietary phosphorus absorption by phosphorus binders. A theoretical, in vitro, and in vivo study","volume":"83","author":"Sheikh","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1053\/jarr.2002.34843_NEWBIB35","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1056\/NEJM198904273201703","article-title":"Effect of the time of administration of calcium acetate on phosphorus binding","volume":"320","author":"Schiller","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1053\/jarr.2002.34843_NEWBIB36","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/ndt\/12.5.961","article-title":"Effect of RenaGel, a non-absorbable, cross-linked, polymeric phosphate binder, on urinary phosphorus excretion in rats","volume":"12","author":"Rosenbaum","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/jarr.2002.34843_NEWBIB37","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/S0272-6386(98)70137-4","article-title":"Influence of pH on in vitro disintegration of phosphate binders","volume":"32","author":"Stamatakis","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/jarr.2002.34843_NEWBIB38","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0300-2977(99)00084-4","article-title":"Efficacy and tolerance of three different calcium acetate formulations in hemodialysis patients","volume":"55","author":"van den Bergh","year":"1999","journal-title":"Netherl J Med"},{"key":"10.1053\/jarr.2002.34843_NEWBIB39","first-page":"373","article-title":"A possible non-aluminum oral phosphate binder? A comparative study on dietary phosphorus absorption","volume":"89","author":"Graff","year":"1995","journal-title":"Res Communic Molec Pathol Pharmacol"},{"key":"10.1053\/jarr.2002.34843_NEWBIB40","first-page":"389","article-title":"Reduction of dietary phosphorus absorption by oral phoshorus binders","volume":"90","author":"Graff","year":"1995","journal-title":"Res Communic Molec Pathol Pharmacol"},{"key":"10.1053\/jarr.2002.34843_NEWBIB41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/039139889802100104","article-title":"Phosphate-binding capacities of calcium and aluminum formulations","volume":"21","author":"Lau","year":"1998","journal-title":"Int J Artif Org"},{"key":"10.1053\/jarr.2002.34843_NEWBIB42","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3109\/08860229909045184","article-title":"Oral phosphate binders: phosphate binding capacity of iron (III) hydroxide complexes containing saccharides and their effect on the urinary excretion of calcium and phosphate in rats","volume":"21","author":"Yamaguchi","year":"1999","journal-title":"Renal Failure"},{"key":"10.1053\/jarr.2002.34843_NEWBIB43","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/oxfordjournals.ndt.a027403","article-title":"Cross-linked iron dextran is an efficient oral phosphate binder in the rat","volume":"11","author":"Spengler","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/jarr.2002.34843_NEWBIB44","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0378-5173(01)00727-X","article-title":"Cross-linking chitosan-Fe(III), an oral phosphate binder: studies in vitro and in vivo","volume":"223","author":"Burger","year":"2001","journal-title":"Int J Pharmaceut"},{"key":"10.1053\/jarr.2002.34843_NEWBIB45","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0272-6386(99)70362-8","article-title":"Phosphate-binding capacity of ferrihydrite versus calcium acetate in rats","volume":"34","author":"Weaver","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/jarr.2002.34843_NEWBIB46","first-page":"51","article-title":"Can low-dosage aluminium hydroxide control the plasma phosphate without bone toxicity?","volume":"4","author":"Jenkins","year":"1989","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/jarr.2002.34843_NEWBIB47","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000187207","article-title":"Long-term (6 months) cross-over comparison of calcium acetate with calcium carbonate as phosphate binder","volume":"63","author":"Ben Hamida","year":"1993","journal-title":"Nephron"},{"key":"10.1053\/jarr.2002.34843_NEWBIB48","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1159\/000186802","article-title":"Calcium acetate versus calcium carbonate as phosphate binders in hemodialysis patients","volume":"60","author":"Caravaca","year":"1992","journal-title":"Nephron"},{"key":"10.1053\/jarr.2002.34843_NEWBIB49","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000186697","article-title":"Control of predialytic hyperphosphatemia by oral calcium acetate and calcium carbonate. Comparable efficacy for half the dose of elemental calcium given as acetate without lower incidence of hypercalcemia","volume":"60","author":"Moriniere","year":"1992","journal-title":"Nephron"},{"key":"10.1053\/jarr.2002.34843_NEWBIB50","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1093\/ndt\/9.8.1121","article-title":"Calcium acetate versus calcium carbonate as phosphate-binding agents in chronic haemodialysis","volume":"9","author":"Pflanz","year":"1994","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/jarr.2002.34843_NEWBIB51","first-page":"341","article-title":"Calcium acetate versus calcium carbonate as phosphorus binders in patients on chronic haemodialysis: A controlled study","volume":"8","author":"Ring","year":"1993","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/jarr.2002.34843_NEWBIB52","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/ndt\/6.3.170","article-title":"The treatment of uraemic hyperphosphataemia with calcium acetate and calcium carbonate: A comparative study","volume":"6","author":"Schaefer","year":"1991","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/jarr.2002.34843_NEWBIB53","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s004670050175","article-title":"Calcium acetate versus calcium carbonate as oral phosphate binder in pediatric and adolescent hemodialysis patients","volume":"10","author":"Wallot","year":"1996","journal-title":"Ped Nephrol"},{"key":"10.1053\/jarr.2002.34843_NEWBIB54","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/ndt\/14.6.1475","article-title":"Calcium ketoglutarate versus calcium acetate for treatment of hyperphosphataemia in patients on maintenance haemodialysis: A cross-over study","volume":"14","author":"Birck","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/jarr.2002.34843_NEWBIB55","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/ajkd.1998.v31.pm9469496","article-title":"Randomized crossover study comparing the phosphate-binding efficacy of calcium ketoglutarate versus calcium carbonate in patients on chronic hemodialysis","volume":"31","author":"Bro","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/jarr.2002.34843_NEWBIB56","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1046\/j.1523-1755.2000.00819.x","article-title":"Comparison of treatments for mild secondary hyperparathyroidism in hemodialysis patients","volume":"57","author":"Indridason","year":"2000","journal-title":"Kidney Int"},{"key":"10.1053\/jarr.2002.34843_NEWBIB57","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis","volume":"342","author":"Goodman","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1053\/jarr.2002.34843_NEWBIB58","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/ki.1990.293","article-title":"Soft tissue calcification in pediatric patients with end-stage renal disease","volume":"38","author":"Milliner","year":"1990","journal-title":"Kidney Int"},{"key":"10.1053\/jarr.2002.34843_NEWBIB59","first-page":"757A","article-title":"Regulation of calcium depositions in an in vitro model of vascular calcification","volume":"12","author":"O'Neill","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/jarr.2002.34843_NEWBIB60","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1161\/01.RES.87.7.e10","article-title":"Phosphate regulation of vascular smooth muscle cell calcification","volume":"87","author":"Jono","year":"2000","journal-title":"Circul Res"},{"key":"10.1053\/jarr.2002.34843_NEWBIB61","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/ki.1996.22","article-title":"Magnesium carbonate as a phosphorus binder: a prospective, controlled, crossover study","volume":"49","author":"Delmez","year":"1996","journal-title":"Kidney Int"},{"key":"10.1053\/jarr.2002.34843_NEWBIB62","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/oxfordjournals.ndt.a091722","article-title":"Magnesium hydroxide as a complementary aluminium-free phosphate binder to moderate doses of oral calcium in uraemic patients on chronic haemodialysis: Lack of deleterious effect on bone mineralisation","volume":"3","author":"Moriniere","year":"1988","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/jarr.2002.34843_NEWBIB63","first-page":"180","article-title":"Long-term use of magnesium hydroxide as a phosphate binder in patients on hemodialysis","volume":"28","author":"Oe","year":"1987","journal-title":"Clin Nephrol"},{"key":"10.1053\/jarr.2002.34843_NEWBIB64","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0272-6386(99)70221-0","article-title":"A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients","volume":"33","author":"Bleyer","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/jarr.2002.34843_NEWBIB65","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1053\/jren.2000.7410","article-title":"Sevelamer with and without calcium and vitamin D: observations from a long-term open-label clinical trial","volume":"10","author":"Chertow","year":"2000","journal-title":"J Renal Nutr"},{"key":"10.1053\/jarr.2002.34843_NEWBIB66","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1093\/ndt\/14.12.2907","article-title":"Long-term effects of sevelamer hydrochloride on the calcium \u00d7 phosphate product and lipid profile of haemodialysis patients","volume":"14","author":"Chertow","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/jarr.2002.34843_NEWBIB67","first-page":"761A","article-title":"Serum bicarbonate levels with sevelamer versus calcium containing phosphate binders in hemodialysis patients","volume":"12","author":"Block","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/jarr.2002.34843_NEWBIB68","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1046\/j.1523-1755.2000.00025.x","article-title":"Transient decrease of serum bicarbonate levels with Sevelamer hydrochloride as the phosphate binder","volume":"57","author":"Gallieni","year":"2000","journal-title":"Kidney Int"},{"key":"10.1053\/jarr.2002.34843_NEWBIB69","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/ndt\/14.4.863","article-title":"Stabilized polynuclear iron hydroxide is an efficient oral phosphate binder in uraemic patients","volume":"14","author":"Hergesell","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/jarr.2002.34843_NEWBIB70","first-page":"388A","article-title":"Results of a randomized, phase III,dose titration, parallel group study of lanthanum carbonate for reduction and maintenance of serum phosphate in chronic hemodialysis patients","volume":"12","author":"Joy","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/jarr.2002.34843_NEWBIB71","first-page":"388A","article-title":"Safety profile of lanthanum carbonate in hemodialysis patients: results from a phase III U.S. study","volume":"12","author":"Joy","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/jarr.2002.34843_NEWBIB72","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/ndt\/14.5.1195","article-title":"Nicotinamide inhibits sodium-dependent phosphate cotransport activity in rat small intestine","volume":"14","author":"Katai","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/jarr.2002.34843_NEWBIB73","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/ndt\/14.3.610","article-title":"Effects of niceritrol on faecal and urinary phosphate excretion in normal rats","volume":"14","author":"Kuboyama","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/jarr.2002.34843_NEWBIB74","first-page":"414A","article-title":"Nicotinamide reduces serum phosphorus levels in hemodialysis patients","volume":"12","author":"Takahashi","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/jarr.2002.34843_NEWBIB75","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000190257","article-title":"Effects of the nicotinic acid analogue niceritrol on lipoprotein Lp(a) and coagulation-fibrinolysis status in patients with chronic renal failure on hemodialysis","volume":"77","author":"Shoji","year":"1997","journal-title":"Nephron"},{"key":"10.1053\/jarr.2002.34843_NEWBIB76","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0306-3623(95)02017-9","article-title":"Use of phosphonocarboxylic acids as inhibitors of sodium-phosphate cotransport","volume":"27","author":"Loghman-Adham","year":"1996","journal-title":"Gen Pharmacol"},{"key":"10.1053\/jarr.2002.34843_NEWBIB77","article-title":"Na\/P co-transporter agonists","author":"Anonymous","year":"2001","journal-title":"Am J Physiol"}],"container-title":["Advances in Renal Replacement Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1073444902700393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1073444902700393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T19:41:29Z","timestamp":1704570089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1073444902700393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7]]},"references-count":77,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,7]]}},"alternative-id":["S1073444902700393"],"URL":"https:\/\/doi.org\/10.1053\/jarr.2002.34843","relation":{},"ISSN":["1073-4449"],"issn-type":[{"value":"1073-4449","type":"print"}],"subject":[],"published":{"date-parts":[[2002,7]]}}}